Title: Cross DA, et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014 Sep;4(9):1046-61.
1421372-66-8
1421373-65-0
1421373-62-7
2134096-03-8
1421373-36-5
1899921-05-1
1324003-64-6 | Tc-g 1006 | AA009CHE | MFCD27991276
1334405-60-5 | Ethyl 3-amino-5-bromopyridine-2-carboxylate | AA009CLZ | MFCD10566234
14324-99-3 | Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)manganese(iii) | AA009D4E | MFCD00269825
121177-93-3 | (METHACRYLOXYMETHYL)METHYLDIMETHOXYSILANE | AA009DDW | MFCD07777082
141831-72-3 | 3-Bromo-5-isopropyl-1h-1,2,4-triazole | AA009DRX | MFCD12197751
1243250-06-7 | 8-Amino-6-fluoro-3,4-dihydro-2(1h)-quinolinone | AA009DVE | MFCD29917908
1312077-05-6 | (3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one | AA009E1Q | MFCD29039357
1390637-82-7 | PF-04981517 | AA009E8F | MFCD22417344
1309112-13-7 | Repaglinide Acyl--D-glucuronide | AA009EFW | MFCD09752144
1219803-12-9 | 4-Ethylguaiacol-d5 | AA009EPN | MFCD06658672
